Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques
- PMID: 19942286
- DOI: 10.1016/j.biomaterials.2009.11.017
Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques
Abstract
A major limitation in tissue engineering is the insufficient formation of blood vessels in implanted tissues, resulting in reduced cell density and graft size. We report here the fabrication of angiogenic cell sheets using a combination of two magnetic force-based techniques which use magnetite cationic liposomes (MCLs), magnetofection and magnetic cell accumulation. A retroviral vector encoding an expression cassette of vascular endothelial growth factor (VEGF) was labeled with MCLs, to magnetically attract the particles onto a monolayer of mouse myoblast C2C12 cells, for gene delivery. MCL-mediated infection increased transduction efficiency by 6.7-fold compared with the conventional method. During the fabrication of the tissue constructs, MCL-labeled cells were accumulated in the presence of a magnetic field to promote the spontaneous formation of a multilayered cell sheet. VEGF gene-engineered C2C12 (C2C12/VEGF) cell sheets, constructed using both magnetic force-based techniques, were subcutaneously transplanted into nude mice. Histological analyses revealed that on day 14 the C2C12/VEGF cell sheet grafts had produced thick tissues, with a high-cell density, and promoted vascularization. This suggests that the method described here represents a powerful strategy in tissue engineering.
(c) 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Genetically engineered myoblast sheet for therapeutic angiogenesis.Biomacromolecules. 2014 Jan 13;15(1):361-72. doi: 10.1021/bm401605f. Epub 2013 Dec 11. Biomacromolecules. 2014. PMID: 24304175
-
Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.Gene Ther. 2001 Apr;8(7):523-33. doi: 10.1038/sj.gt.3301436. Gene Ther. 2001. PMID: 11319619
-
Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue.BJU Int. 2008 Sep;102(7):878-84. doi: 10.1111/j.1464-410X.2008.07750.x. Epub 2008 May 16. BJU Int. 2008. PMID: 18489526
-
Tissue engineering using magnetite nanoparticles.Prog Mol Biol Transl Sci. 2011;104:355-95. doi: 10.1016/B978-0-12-416020-0.00009-7. Prog Mol Biol Transl Sci. 2011. PMID: 22093224 Review.
-
Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.Br J Pharmacol. 2003 Oct;140(4):620-6. doi: 10.1038/sj.bjp.0705492. Br J Pharmacol. 2003. PMID: 14534145 Free PMC article. Review.
Cited by
-
One-step fabrication of cell sheet-laden hydrogel for accelerated wound healing.Bioact Mater. 2023 Jun 20;28:420-431. doi: 10.1016/j.bioactmat.2023.06.005. eCollection 2023 Oct. Bioact Mater. 2023. PMID: 37519924 Free PMC article.
-
Advanced physical techniques for gene delivery based on membrane perforation.Drug Deliv. 2018 Nov;25(1):1516-1525. doi: 10.1080/10717544.2018.1480674. Drug Deliv. 2018. PMID: 29968512 Free PMC article. Review.
-
Liposomes in tissue engineering and regenerative medicine.J R Soc Interface. 2014 Dec 6;11(101):20140459. doi: 10.1098/rsif.2014.0459. J R Soc Interface. 2014. PMID: 25401172 Free PMC article. Review.
-
Effects of B-cell lymphoma 2 gene transfer to myoblast cells on skeletal muscle tissue formation using magnetic force-based tissue engineering.Tissue Eng Part A. 2013 Jan;19(1-2):307-15. doi: 10.1089/ten.TEA.2011.0728. Epub 2012 Nov 21. Tissue Eng Part A. 2013. PMID: 23088454 Free PMC article.
-
Application of magnetism in tissue regeneration: recent progress and future prospects.Regen Biomater. 2024 May 7;11:rbae048. doi: 10.1093/rb/rbae048. eCollection 2024. Regen Biomater. 2024. PMID: 38939044 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources